Invention Grant
- Patent Title: Method of synthesising ADCs using affinity resins
-
Application No.: US14786387Application Date: 2014-04-25
-
Publication No.: US10201544B2Publication Date: 2019-02-12
- Inventor: David J. Evans , Colin M. McKee
- Applicant: ADC Biotechnology Ltd.
- Applicant Address: GB St. Asaph
- Assignee: ADC Biotechnology Ltd.
- Current Assignee: ADC Biotechnology Ltd.
- Current Assignee Address: GB St. Asaph
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon; Alexander J. Chatterley
- Priority: GB1307574.2 20130426
- International Application: PCT/GB2014/051304 WO 20140425
- International Announcement: WO2014/174316 WO 20141030
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K31/5365 ; A61K38/05 ; C07K16/28 ; C07K16/40 ; A61K47/68

Abstract:
This invention relates to a solid phase method of synthesizing biomolecule-drug conjugates. In particular, this invention relates to a solid phase method of synthesizing antibody-drug conjugates (ADCs). This invention also relates to intermediate methods of producing immobilized, chemically modified biomolecules, e.g. antibodies. The invention also relates to various uses of capture resins and to biomolecule-drug conjugates, intermediate products and compositions prepared by the methods of the invention.
Public/Granted literature
- US20160067352A1 Method of Synthesising ADCs Using Affinity Resins Public/Granted day:2016-03-10
Information query